High Blood Pressure
References
American Heart Association. Heart Disease and Stroke Statistics — 2005 Update. http://www.americanheart.org/downloadable/heart/1105390918119HDSStats2005Update.pdf. Accessed July 6, 2006.
Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001 Sep;158(1):195-8.
Bentivegna SS, Whitney KM. Subchronic 3-month oral toxicity study of grape seed and grape skin extracts. Food Chem Toxicol. 2002 Dec;40(12):1731-43.
Bharani A, Ahirwar LK et al. Terminalia arjuna reverses impaired endothelial function in chronic smokers. Indian Heart J. 2004 Mar;56(2):123-8.
Boger RH, Ron ES. L-arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. Altern Med Rev. 2005 Mar;10(1):14-23.
Burke BE, Neuenschwander R et al. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001 Nov;94(11):1112-7.
Chang WT, Dao J et al. Hawthorn: potential roles in cardiovascular disease. Am J Chin Med. 2005;33(1):1-10.
Cherif S, Rahal N et al. A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension [in French]. J Pharm Belg. 1996 Mar-Apr;51(2):69-71.
Chew GT, Watts GF. Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the recoupling hypothesis. QJM. 2004 Aug;97(8):537-48.
Chobanian AV, Bakris GL et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52.
Cohuet G, Struijker-Boudier H. Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther. 2006 Jul;111(1):81-98.
Collins R, Peto R et al. Blood pressure, stroke, and coronary heart disease: part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827-38.
Corder R, Warburton RC et al. The procyanidin-induced pseudo laminar shear stress response: a new concept for the reversal of endothelial dysfunction. Clin Sci (Lond). 2004 Nov;107(5):513-7.
Cuevas AM, Germain AM. Diet and endothelial function. Biol Res. 2004;37(2):225-30.
Din JN, Newby DE et al. Omega 3 fatty acids and cardiovascular disease: fishing for a natural treatment. BMJ. 2004 Jan 3;328(7430):30-5.
Duffy SJ, Gokce N et al. Treatment of hypertension with ascorbic acid. Lancet. 1999 Dec 11;354(9195):2048-9.
Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India. 1994 Apr;42(4):287-9.
Edwards QT, Colquist S et al. What's cooking with garlic: is this complementary and alternative medicine for hypertension? J Am Acad Nurse Pract. 2005 Sep;17(9):381-5.
Fahey T. Valuable insights from morbidity coding in primary care. BMJ. 2004 May 8;328(7448):1113.
Felmeden DC, Lip GY. Endothelial dysfunction and its assessment. Expert Opin Investig Drugs. 2005 Nov;14(11):1319-36.
Folkers K, Langsjoen P et al. Biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory treatment. Biochem Biophys Res Commun. 1988 Jun 16;153(2):888-96.
Fujita T, Ando K et al. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation. 1987 Mar;75(3):525-32.
Galley HF, Thornton J et al. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond). 1997 Apr;92(4):361-5.
Geleijnse JM, Kok FJ et al. Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations. Eur J Public Health. 2004 Sept;14(3):235-9.
Gil MI, Tomas-Barberan FA et al. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem. 2000 Oct;48(10):4581-9.
Guerrero-Romero F, Tamez-Perez HE et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance: a double-blind, placebo-controlled, randomized trial. Diabetes Metab. 2004 Jun;30(3):253-8.
Hausberg M, Lang D et al. Large artery wall properties: what is relevant for the management of hypertension? Dtsch Med Wochenschr. 2005 Nov 18;130(46):2657-61.
He J, Gu D et al. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med. 2005 Jul 5;143(1):1-9.
Hirafuji M, Machida T et al. Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J Pharmacol Sci. 2003 Aug;92(4):308-16.
Hodgson JM, Watts GF et al. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002 Nov;56(11):1137-42.
Hyman DJ, Pavlik VN. Poor hypertension control: let’s stop blaming the patients. Cleve Clin J Med. 2002 Oct;69(10):793-9.
Ignarro LJ, Byrns RE et al. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide. 2006 Apr 18; [Epub ahead of print].
Inoue I. Lipid metabolism in magnesium. Clin Calcium. 2005 Nov;15(11):1827-38.
Kannel WB. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res. 1995 Sep;18(3):181-96.
Kannel WB, Oparil S et al. Oparil S, Weber A, eds. Hypertension: A Companion to Brenner and Rector’s The Kidney. 2nd ed. London, England: Elsevier Saunders; 2005.
Kannel WB. Prevalence and implications of uncontrolled systolic hypertension. Drugs Aging. 2003;20(4):277-86.
Karaki H, Doi K et al. Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comp Biochem Physiol C. 1990;96(2):367-71.
Kasper DL, Braunwald E et al, eds. Harrison’s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.
Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension. 2005 Aug;46(2):249-54.
Khosh F, Khosh M. Natural approach to hypertension. Altern Med Rev. 2001 Dec;6(6):590-600.
Kitiyakara C, Wilcox CS. Antioxidants for hypertension. Curr Opin Nephrol Hypertens. 1998 Sep;7(5):531-8.
Klag MJ, Izzo JL et al, eds. Renal risk. In: Hypertension Primer: The Essentials of High Blood Pressure. 3rd ed. Washington, DC: American Heart Association; 2003:246-9.
Kumeda Y, Inaba M. Metabolic syndrome and magnesium. Clin Calcium. 2005 Nov;15(11):1859-66.
Kurabayashi M. Role of magnesium in cardiac metabolism. Clin Calcium. 2005 Nov;15(11):1839-45.
Langsjoen P, Langsjoen P et al. Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med. 1994;15(suppl):S265-72.
Lansky EP. Beware of pomegranates bearing 40% ellagic acid. J Med Food. 2006;9(1):119-22.
Leuchtgens H. Crataegus Special Extract WS 1442 in NYHA II heart failure: a placebo-controlled, randomized, double-blind study [in German]. Fortschr Med. 1993 Jul;20;111(20-21):352-4.
Lloyd-Jones DM, Evans JC et al. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005 Jul 27;294(4):466-72.
Mayer-Davis EJ, Costacou T et al. Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care. 2002 Dec;25(12):2172-7.
Militante JD, Lombardini JB. Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids. 2002;23(4):381-93.
National Institutes of Health. The DASH eating plan. Available at: www.nhlbi.nih.gov/health/public/heart/hbp/dash. Accessed June 26, 2006.
Natoli AK, Medley TL et al. Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension. 2005 Nov;46(5):1129-34.
Palmieri V, Storto G et al. Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. J Hum Hypertens. 2005 Dec;19(12):941-50.
Rasmussen C, Cynober L et al. Arginine and statins: relationship between the nitric oxide pathway and the atherosclerosis development. Ann Biol Clin (Paris). 2005 Sep-Oct;63(5):443-55.
Rosanoff A. Magnesium and hypertension. Clin Calcium. 2005 Feb;15(2):255-60.
Sammour MB, el-Kabarity H et al. Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens. J Steroid Biochem Mol Biol. 2005 Dec; 97(5):439-40.
Schussler M, Holzl J et al. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung. 1995 Aug;45(8):842-5.
Sekiya S, Kobayashi Y et al. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J Jpn Soc Nutr Food Sci. 1992;45:513-7.
Siani A, Pagano E, et al. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens. 2000 May;13(pt 1):547-51.
Siva B, Edirisinghe I et al. Effect of polyphenolics extracts of grape seeds (GSE) on blood pressure (BP) in patients with metabolic syndrome (MetS). FASEB. 2006 [Epub ahead of print].
Song Y, Ridkey PM et al. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005 Jun;28(96):1438-44.
Swales JD. Textbook of Hypertension. Oxford, England: Blackwell Scientific Publications; 1994.
Taber M, Council for Responsible Nutrition. Largest trial of vitamin E shows heart health benefit for women. Available at www.crnusa.org. Accessed June 26, 2006.
Tankanow R, Tamer HR et al. Interaction study between digoxin and a preparation of hawthorn. J Clin Pharmacol. 2003 Jun;43(6):637-42.
Tattelman E. Health effects of garlic. Am Fam Physician. 2005 Jul 1;72(1):103-6.
Touyz RM, Campbell N et al. The 2004 Canadian recommendations for the management of hypertension: part III: lifestyle modifications to prevent and control hypertension. Can J Cardiol. 2004 Jan;20(1):55-9.
Townsend RR, McFadden CB et al. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens. 2004 Nov;17(pt 1):1056-8.
Vasan RS, Massaro JM et al. Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2002 Jan 1;105(1):48-53.
Walker AF, Marakis G et al. Promising hypotensive effect of hawthorn extract: a randomized, double-blind, pilot study of mild, essential hypertension. Phytother Res. 2002 Feb;16(1):48-54.
Watts GF, Playford DA et al. Coenzyme Q10 improves endothelial dysfunction of the brachial artery in type II diabetes. Diabetologia. 2002 May;45(3):420-6.
Wirell MP, Wester PO et al. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. J Intern Med. 1994 Aug;236(2):189-95.
Wolf PA. Fifty years at Framingham: contributions to stroke epidemiology. Adv Neurol. 2003;92:165-72.
Wong ND, Franklin SS et al. Epidemiology of hypertension. Oparil S, Weber A, eds. Hypertension: A Companion to Brenner and Rector’s The Kidney. 2nd ed. London, England: Elsevier Saunders; 2005:16-28.
Yang G, Shu XO et al. Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr. 2005 May;81(5):1012-7.